Safety of trastuzumab deruxtecan: A meta‐analysis and pharmacovigilance study

WHAT IS KNOWN AND OBJECTIVE: This study aimed to explore the safety profile of trastuzumab deruxtecan (T‐DXd, formerly DS‐8201a) using multi‐source medical data. METHODS: We explored trastuzumab deruxtecan related adverse events (AEs) in clinical trials available in ClinicalTrials.gov and electronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zihan, Ding, Yunlan, Wang, Mengmeng, Liu, Jiyong, Zhai, Qing, Du, Qiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827941/
https://www.ncbi.nlm.nih.gov/pubmed/36200429
http://dx.doi.org/10.1111/jcpt.13777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827941/
https://www.ncbi.nlm.nih.gov/pubmed/36200429
http://dx.doi.org/10.1111/jcpt.13777

Ejemplares similares